Legal & General Group Plc lowered its stake in MiMedx Group, Inc (NASDAQ:MDXG) by 0.3% during the first quarter, Holdings Channel reports. The institutional investor owned 165,770 shares of the medical equipment provider’s stock after selling 525 shares during the period. Legal & General Group Plc’s holdings in MiMedx Group were worth $1,579,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. State of Alaska Department of Revenue increased its stake in shares of MiMedx Group by 1.3% in the first quarter. State of Alaska Department of Revenue now owns 11,100 shares of the medical equipment provider’s stock valued at $105,000 after buying an additional 140 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in shares of MiMedx Group by 0.7% in the first quarter. Louisiana State Employees Retirement System now owns 40,800 shares of the medical equipment provider’s stock valued at $389,000 after buying an additional 300 shares in the last quarter. Arizona State Retirement System increased its stake in shares of MiMedx Group by 0.6% in the first quarter. Arizona State Retirement System now owns 52,216 shares of the medical equipment provider’s stock valued at $498,000 after buying an additional 300 shares in the last quarter. PNC Financial Services Group Inc. increased its stake in shares of MiMedx Group by 0.5% in the first quarter. PNC Financial Services Group Inc. now owns 103,931 shares of the medical equipment provider’s stock valued at $992,000 after buying an additional 517 shares in the last quarter. Finally, Cutter & CO Brokerage Inc. increased its stake in shares of MiMedx Group by 5.2% in the first quarter. Cutter & CO Brokerage Inc. now owns 20,150 shares of the medical equipment provider’s stock valued at $192,000 after buying an additional 1,000 shares in the last quarter. 55.76% of the stock is owned by hedge funds and other institutional investors.

Shares of MiMedx Group, Inc (NASDAQ MDXG) opened at 14.84 on Friday. MiMedx Group, Inc has a one year low of $6.94 and a one year high of $16.20. The firm has a market capitalization of $1.57 billion, a P/E ratio of 106.00 and a beta of 1.04. The company’s 50 day moving average price is $14.95 and its 200 day moving average price is $11.30.

MiMedx Group (NASDAQ:MDXG) last released its quarterly earnings results on Friday, April 28th. The medical equipment provider reported $0.07 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.07. MiMedx Group had a return on equity of 12.25% and a net margin of 5.72%. The company had revenue of $72.60 million during the quarter, compared to analysts’ expectations of $72.60 million. During the same quarter in the prior year, the business posted $0.04 earnings per share. The company’s revenue for the quarter was up 36.1% compared to the same quarter last year. On average, analysts expect that MiMedx Group, Inc will post $0.30 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/07/23/legal-general-group-plc-sells-525-shares-of-mimedx-group-inc-mdxg.html.

Several equities research analysts recently weighed in on the company. BidaskClub downgraded MiMedx Group from a “buy” rating to a “hold” rating in a report on Wednesday, July 5th. Needham & Company LLC reaffirmed a “buy” rating and set a $15.00 price target (up from $12.00) on shares of MiMedx Group in a report on Thursday, April 13th. Finally, First Analysis downgraded MiMedx Group from an “equal weight” rating to an “underweight” rating and set a $11.00 price target for the company. in a report on Tuesday, May 23rd. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $12.40.

In other news, insider William Charles Taylor sold 80,000 shares of the stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $14.52, for a total value of $1,161,600.00. Following the completion of the transaction, the insider now owns 547,424 shares of the company’s stock, valued at $7,948,596.48. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last three months, insiders sold 132,571 shares of company stock valued at $1,823,086. Company insiders own 12.40% of the company’s stock.

About MiMedx Group

MiMedx Group, Inc is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.

Want to see what other hedge funds are holding MDXG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MiMedx Group, Inc (NASDAQ:MDXG).

Institutional Ownership by Quarter for MiMedx Group (NASDAQ:MDXG)

Receive News & Stock Ratings for MiMedx Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group Inc and related stocks with our FREE daily email newsletter.